Breaking Down China Reinsurance (Group) Corporation Financial Health: Key Insights for Investors

Investors scrutinizing China Reinsurance Corporation (1508.HK) will find a complex mix of resilience and opportunity: H1 2025 revenue rose to CNY 53.02 billion (+15.07% YoY) while TTM revenue through Oct 24, 2025 was CNY 103.25 billion (0.91% YoY) and 2024 full-year revenue hit CNY 103.66 billion (+9.17%); profitability shows H1 net income of CNY 6.24 billion (EPS CNY 0.15) and TTM net income CNY 12.13 billion (EPS CNY 0.29) with a 10.18% profit margin and ROE of 10.31%; balance-sheet strength is underscored by CNY 516.45 billion in assets, CNY 460.85 billion liabilities (debt-to-equity ≈ 0.62), a group core solvency adequacy ratio of 324%, cash and short-term deposits of CNY 18.54 billion, and liquidity ratios (current 3.07, quick 2.05) alongside an interest coverage of 7.40; valuation metrics point to potential undervaluation with market cap HKD 68.39 billion, P/E around 5.81 (trailing) and intrinsic value estimated at HKD 7.19 (implying a large upside from the current HKD 1.62), while a 52-week range of HKD 0.66-1.83 and a beta of 0.88 highlight stock volatility and relative market stability-keep reading for a line-by-line breakdown of revenue drivers, margin dynamics, capital structure moves (including Sept 2025 approval for up to RMB 4.0 billion in 10-year redeemable capital supplementary bonds), valuation scenarios, and the key risks and growth levers investors should weigh.

China Reinsurance Corporation (1508.HK) - Revenue Analysis

• H1 2025 revenue: CNY 53.02 billion (up 15.07% year‑over‑year).
• TTM revenue as of 24 Oct 2025: CNY 103.25 billion (up 0.91% YoY).
• Full-year 2024 revenue: CNY 103.66 billion (up 9.17% vs. 2023).

• Drivers behind H1 2025 strength: likely underwriting income recovery and/or improved investment returns (H1 growth at +15.07%).
• Why TTM growth is muted (+0.91%): strong 2024 base (CNY 103.66bn) makes incremental full‑year gains modest; seasonality and claim volatility may compress YoY TTM growth.
• Operational efficiency signal: revenue per employee ~CNY 2.11m - useful for benchmarking against peers in P/C reinsurance and diversified insurance conglomerates.
• Valuation context: P/S of 0.60 with market cap HKD 68.39bn suggests the market prices in modest growth and/or margin risk; paired with a wide 52‑week range (HKD 0.66-1.83) indicates investor uncertainty and liquidity-driven price swings.

China Reinsurance Corporation (1508.HK) - Profitability Metrics

• H1 2025 net income: CNY 6.24 billion (vs CNY 5.73 billion in H1 2024)
• H1 2025 EPS: CNY 0.15 (vs CNY 0.13 in H1 2024)
• TTM net income (as of 2025-10-24): CNY 12.13 billion; TTM EPS: CNY 0.29
• FY2024 profit margin: 10.18%; operating margin: 13.50%
• TTM ROE: 10.31%; TTM ROA: 1.83%
• Current P/E: 5.81; Forward P/E: 6.98
• Dividend yield: 3.33% (ex-dividend date: 2025-07-02)

• Implication: improving profitability metrics (net income, EPS, margins) alongside low P/E multiples suggest attractive risk-adjusted valuation for investors seeking insurance-sector exposure.
• Consider cross-referencing capital adequacy, underwriting results, and investment portfolio returns to contextualize ROE/ROA persistence.

China Reinsurance Corporation (1508.HK) - Debt vs. Equity Structure

• Equity-dominant balance sheet: implied equity (Assets - Liabilities) ≈ CNY 55.60 billion, underpinning the 0.62 debt-to-equity ratio.
• Capital strength: 324% core solvency adequacy indicates regulatory capital well above minimums.
• Liquidity cushion: current ratio 3.07 and quick ratio 2.05 reduce short-term funding risk.
• Debt serviceability: interest coverage of 7.40 suggests robust earnings relative to interest costs.
• Funding flexibility: approved RMB 4.0 billion 10-year redeemable bonds (Sep 2025) provide supplementary capital without immediate equity dilution.

China Reinsurance Corporation (1508.HK) - Liquidity and Solvency

• Cash and short-term time deposits (as of June 30, 2025): CNY 18.54 billion - a significant liquidity buffer available for underwriting needs, claims and short-term obligations.
• Core solvency adequacy ratio (group level): 324% - well above typical regulatory minimums, indicating ample capital cushion against underwriting and market stresses.
• Current ratio: 3.07 and quick ratio: 2.05 - signaling strong short-term liquidity and ability to meet imminent liabilities without reliance on inventory or longer-term assets.
• Interest coverage ratio: 7.40 - the company's operating earnings cover interest expenses comfortably, reducing refinancing and leverage risk.

• Capital issuance: In September 2025 China Re P&C received approval to issue up to RMB 4.0 billion of 10-year redeemable capital supplementary bonds - this transaction expands available regulatory capital and strengthens the group's solvency profile for medium-term expansion.
• Valuation and cash conversion: EV/EBITDA of 7.71 and EV/FCF of 8.80 reflect efficient capital structure and relatively strong free cash flow generation versus enterprise valuation.
• Risk considerations: Despite strong ratios, investors should monitor underwriting cycles, investment portfolio mark-to-market volatility and any changes in regulatory capital rules that could affect required buffers.

China Reinsurance Corporation (1508.HK) - Valuation Analysis

• Intrinsic value estimate (16-Dec-2025): HKD 7.19 per share, implying a potential upside of 343.88% from the market price of HKD 1.62.
• Market capitalization: HKD 68.39 billion; beta: 0.88 (lower volatility vs. market).
• 52-week range: HKD 0.66 - HKD 1.83, reflecting material intrayear volatility.

• Valuation posture: Across P/E, P/S, P/B and EV multiples, China Reinsurance Corporation (1508.HK) displays metrics consistent with marked undervaluation relative to typical industry benchmarks.
• Risk considerations tied to the large gap between market price and intrinsic value include execution risk, macro/interest-rate shifts, underwriting cycles, and possible model assumptions driving the intrinsic estimate.
• Volatility note: 52-week range shows both downside realized and recent proximity to the high end (HKD 1.83), implying price momentum can move quickly despite low beta.

China Reinsurance Corporation (1508.HK) - Risk Factors

• Underwriting volatility: China Re's profitability is sensitive to claims frequency and severity across property, casualty, and specialty lines. Historical combined ratios have fluctuated, reflecting cycle-driven pricing and reserve strengthening.
• Catastrophe exposure: Concentrated exposure to nat-cat events in China and across Asia can produce large, lump-sum claim shocks in a single year.
• Regulatory risk: Changes to capital requirements, reserving rules, or market access (domestic and cross‑border) can affect capital allocation, product offerings, and reported results.
• Interest rate sensitivity: Investment income and the market value of fixed‑income portfolios move with interest rates; prolonged low rates compress investment margins while rapid rises can create mark‑to‑market losses on longer-duration assets.
• FX exposure: As China Re conducts reinsurance and investment activity across currencies, RMB, USD and HKD swings can affect translated results and the value of foreign securities.
• Competitive pressures: Global and domestic reinsurers competing on price and capacity can force margin compression, especially in soft market cycles.

• Capital & liquidity considerations: Maintaining regulatory capital ratios and ready liquidity for large claim payouts is essential; stress scenarios (severe nat-cat + market shock) are particularly informative for investors.
• Reserve adequacy: Reserve strengthening or adverse development on prior years' loss reserves can materially affect retained earnings; monitor reserve movement in quarterly/annual disclosures.
• Reinsurance purchased vs. retained risk: The company's net exposure profile depends on its retrocession strategy-higher retention boosts upside in benign years but increases tail risk in catastrophes.

China Reinsurance Corporation (1508.HK) - Growth Opportunities

• Emerging market expansion: Asia, Africa and Latin America are growing reinsurance consumers as primary insurers expand. Target markets with higher insurance penetration growth (annual premiums growing 6-10% p.a.) can materially increase ceded premium flows.
• New product development: Parametric covers, cyber, supply-chain and climate-linked reinsurance are higher-margin niches. Global parametric and catastrophe-linked premiums are projected to grow at double-digit CAGRs over the next 5-7 years.
• Strategic partnerships & M&A: JV arrangements and bolt-on acquisitions can accelerate market entry and distribution. Small- to mid-sized treaty portfolio acquisitions (e.g., portfolios generating RMB 1-5bn in GWP) can meaningfully lift scale in focused regions.
• Technology & analytics: Investment in predictive modeling, telematics and real-time exposure management can reduce combined ratios by several percentage points and improve capital efficiency (lower required economic capital for same risk appetite).
• Climate and environmental products: Growing demand for flood, windstorm and agricultural weather products-markets where annual insured losses are trending upward-presents revenue upside; climate-linked insurance premiums worldwide are expected to expand fast as protection gaps narrow.
• Digital platforms & customer engagement: Improved digital distribution and straight-through processing can increase retention and reduce acquisition costs; digital-first channels often deliver 10-30% lower transaction costs versus legacy channels.

• Capital and rating: Strengthening solvency and optimizing capital allocation (reinsurance retrocession, cat bonds, sidecars) increases capacity to write higher-return business without diluting ROE.
• Distribution optimization: Focusing on bancassurance partners, digital brokers and direct primary insurer relationships reduces dependency on single channels and improves premium velocity.
• Product packaging: Bundling parametric elements with traditional treaty covers can accelerate adoption and allow for pricing differentiation.